Drug archive
Zalcitabine (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antiviral, systemic
Description
Zalcitabine (zal-SITE-a-been) (also known as ddC) is used in the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS).
Zalcitabine (ddC) will not cure or prevent HIV infection or AIDS; however, it helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay the development of problems usually related to AIDS or HIV disease. Zalcitabine will not keep you from spreading HIV to other people. People who receive this medicine may continue to have other problems usually related to AIDS or HIV disease.
Zalcitabine may cause some serious side effects, including peripheral neuropathy (a problem involving the nerves). Symptoms of peripheral neuropathy include tingling, burning, numbness, or pain in the hands or feet. Zalcitabine may also cause pancreatitis (inflammation of the pancreas). Symptoms of pancreatitis include stomach pain, and nausea and vomiting. Check with your doctor if any new health problems or symptoms occur while you are taking zalcitabine .
Zalcitabine is available only with your doctor's prescription, in the following dosage form:
- Tablets (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- HIVID
In Canada -
- HIVID
Another commonly used name is ddC .